| INTRODUCTION ngioimmunoblastic T-cell lymphoma (AITL) is a distinct subtype of nodal peripheral T-cell lymphoma (PTCL).
1 A large percentage of patients (68%-94%) present with advanced-stage disease (stages III-IV) at diagnosis. 2 High fever, skin rash, hepatosplenomegaly, pleural effusions, and generalized lymphadenopathy are predominant clinical features of AITL.
Autoimmune-like manifestations including hemolytic anemia and polyclonal hypergammaglobulinemia are also frequently observed. AITL tumor cells display features of follicular helper T (T FH ) cells. 3 Recurrent genetic abnormalities frequently found in AITL include mutations in RHOA (50%-70%), [4] [5] [6] TET2 (47%-83%), 4, 7, 8 IDH2 (20%-45-%), 4, 9 DNMT3A (20%-30%), 4, 7, 10 and CD28 (9.4%-11.3%). [11] [12] [13] The vast majority of RHOA mutations found in AITL are c.50G > T, p.Gly17Val
(G17V RHOA mutations), [4] [5] [6] although different RHOA mutations at the p.Gly17 position (c.49_51del, p.Gly17del, 4 c.[50G > T;51A > C], p.Gly17Leu, 14 and c.50G > A, p. Gly17Leu 6 ) were reported. Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a T-cell lymphoma that cannot be categorized into any subtypes of PTCL (although some PTCL-NOS cases show tumor cells with T FH -like features 4, 8 ). 1 In 2016, the revised WHO classification used an umbrella category for nodal T-cell lymphomas with T FH phenotype that comprise AITL, follicular T-cell lymphoma (FTCL), and nodal PTCL with T FH phenotype. 1 The G17V RHOA mutations, which are extremely rare in the other hematological cancers, are found in approximately 60% of cases of nodal PTCL with T FH phenotype. 4, 11 The frequent and specific distribution of G17V
RHOA mutations in AITL and nodal PTCL with T FH phenotype highlights the diagnostic value of this mutation for these subtypes of PTCL.
In clinical practice, routine detection of G17V RHOA mutations is challenging as a result of the low ratio of tumor cells in AITL tissues.
Additionally, insufficient quality of genomic DNA derived from biopsy specimens hinders efficient and robust mutation testing. Hence, optimized methods capable of overcoming these problems are needed for detecting G17V RHOA mutations in the clinical setting. In the present study, we carried out extensive analyses of G17V RHOA mutations using droplet digital PCR (ddPCR), peptide nucleic acid-locked nucleic acid (PNA-LNA) clamp method, and next-generation sequencing (NGS)
to clarify the concordance and sensitivity of these methods.
| MATERIALS AND METHODS

| Patients
Sixty-seven patients with PTCL (40 AITL and 27 PTCL-NOS) were included into this retrospective study (Table S1 ). Sequencing data were analyzed using Variant Caller 5.0 (Thermo Fisher Scientific). Results of RHOA mutation analysis of 50 PTCL samples using NGS were previously described (Table S2) . 16 
| ddPCR assay
The PCR primer/probe mix for the G17V RHOA mutation was purchased from Bio-Rad (Hercules, CA, USA). The probe fluorophores used for mutant and wild-type DNA were FAM and HEX, respectively. A 20-lL reaction mixture containing 10 lL ddPCR supermix for probe (no dUTP) 9 2 (Bio-Rad), 1 lL of 10 lmol/L primer/probe mix, and 40 ng DNA template was mixed with 70 lL droplet generation oil through microfluidics in the Droplet Generator (Bio-Rad). Following droplet generation, the water-in-oil droplets were transferred to a standard 96-well PCR plate, which was heat sealed with a foil plate seal (Bio-Rad) and placed on a Bio-Rad thermocycler for PCR amplification using the following protocol: 10 minutes at 95°C, followed by 40 cycles of 30 seconds at 94°C, and 60 seconds at 53.1°C, followed by a 10-minute hold at 98°C. Upon completion of the PCR, the plate was transferred to a Droplet Reader (Bio-Rad).
The data were initially analyzed using QuantaSoft software (BioRad). The fluorescence threshold was set at 5000 for FAM and 2000 for HEX. Wells with less than 3 positive oil droplets were considered as negative, except for wells with 2 positive droplets showing reproducible results, which were considered as positive. Table S3 . Quantitative PCR was then carried out with a 30 seconds hold at 95°C followed by 45 cycles at 95°C for 3 seconds, and 62°C for 30 seconds.
| Statistical analysis
Statistical analysis was conducted using SPSS software (IBM Japan, Tokyo, Japan). The correlation between variant allele frequencies (VAF) from ddPCR assay and those from NGS was analyzed using Spearman's correlation coefficient. P-value <.05 was considered statistically significant.
3 | RESULTS
| Mutation detection sensitivity of ddPCR assay
At first, we established the lower limits of detection (LOD) and quantification (LOQ) for ddPCR assay. For this, serial dilution samples were prepared to make the VAF of the G17V mutation at 13%, 3.25%, 0.81%, 0.20%, 0.05%, 0.01%, and 0.0025%. WT genomic DNA and distilled water (DW) were used as negative control and no template control, respectively ( Figure S1A ). Analysis of the result using ddPCR assay showed highly concordant VAFs with input DNA templates (R 2 = .9996) ( Figure S1A ).
After being converted to log-log scale, data showed precision and linearity down to a dilution of 0.05%; which corresponded to a fractional abundance (proportion of the mutated DNA; QuantaSoft)
] was .9996). The positive control diluted to 0.01% was also judged as positive using ddPCR assay, whereas the fractional abundance was 0.02% ( Figure S1A ).
Mutant alleles at a frequency of <0.01% could not be detected and, thus, <0.01% was considered as negative.
For these reasons, LOQ of ddPCR assay was defined as 0.05% with a fractional abundance of 0.06%. Further experiments showed that LOD could be lowered to 0.01% with a fractional abundance of 0.02%.
3.2 | Mutation detection sensitivity of the PNA-
LNA clamp method
Next, we investigated the detection limit of the PNA-LNA PCR clamp method for the G17V RHOA mutation. The mutant DNA was mixed with WT DNA to generate different dilution samples at 1%, 0.1%, 0.01%, and 0.001% ( Figure S1B ). The PNA-LNA PCR clamp method was able to detect the G17V RHOA sequence at dilutions down to 0.01% but not 0.001% ( Figure S1B) . Because of the limitation of this method, we could not measure the quantity of the mutations.
| Comparison of mutations detected by different methods
Using the data from the 67 PTCL samples we compared the concordance rates of the above-mentioned 3 methods (Table S2 ; Figure 1 ). Table S2 ). ddPCR assay and PNA-LNA clamp method could detect low mutant alleles in 4 cases, which
were not detected with NGS (PTCL171, PTCL186, PTCL209, and PTCL259; Figure 2 ). The mutation ratio according to ddPCR assay was 0.13%, 0.03%, 0.05%, and 0.21% for PTCL171, PTCL186, PTCL209, and PTCL259, respectively. Amplification curves of these samples produced using the PNA-LNA clamp method were also clearly distinguishable from the WT ( Figure 2B ). were positive for the c.50G > T, p.Gly17Val RHOA mutations with both the ddPCR assay and the PNA-LNA method (Figure 1A ,C; Table S2 ), indicating that the results of these two methods were 100% concordant for detecting positive and negative samples (Fig- ure 1A,C; Table S2 ). Furthermore, the data showed that the ddPCR assay and the PNA-LNA method have higher sensitivity than NGS for detecting G17V RHOA mutations in samples.
According to the quantitative results of the ddPCR assay, mutation ratio in the ddPCR assay and VAF in NGS were statistically correlated (Spearman's correlation coefficient 0.868, P-value <.001) (Figure 3 ). Inter-method discrepancies more than double were found in 2 samples (PTCL252 with a VAF of 19.8% in NGS and a mutation ratio of 4.6% in ddPCR assay; PTCL245 with a VAF of 76.4% in NGS and a mutation ratio of 14.28% in ddPCR assay). (Table S2 ; Figure 1B ,D). We found that the results of the ddPCR and PNA-LNA clamp methods were concordant (j = 1 and P < .0001). In addition, the kappa and P-values were .82 and <.0001, respectively, for both ddPCR and NGS, and PNA-LNA clamp method and NGS. We considered those samples as true positive which were positive by at least 2 methods (among ddPCR, PNA-LNA clamp method, NGS, and Sanger sequencing). Moreover, those samples that were negative by all 4 above-mentioned methods were considered as true negative. There were no samples in which RHOA mutations were detected by 1 method only. As a result, the sensitivity of 
| DISCUSSION
RHOA mutation detection has been increasingly focused for diagnosis of AITL and PTCL with T FH phenotype. 14,17 Herein, we clarified that the ddPCR assay and the PNA-LNA clamp method could detect low allele mutations with extremely high sensitivity. In addition, mutation quantification by ddPCR assay showed results concordant with those by NGS. Although we found some discordances in VAF of 2 samples (PTCL245 and PTCL252), insufficient DNA quantity and quality may account for the discordant results, which is sometimes experienced in clinical settings. In contrast, the other RHOA mutations at the p.Gly17 position, which were detected by NGS could not be appropriately detected by either ddPCR assay or the PNA-LNA clamp method. As a result, combination of these methods increased the detection rate of RHOA mutations at the p.Gly17 position. We recently reported essential downstream signaling of G17V
RHOA mutations in PTCL: the G17V mutant RHOA hyper-activated the T-cell receptor (TCR) signaling pathway through specific binding to VAV1 protein, an essential component in TCR signaling. 16 The other RHOA mutants at the p.Gly17 position presumably have a similar function, although it has not been examined.
There are several well-established methods to detect gene mutations in cancers. Among them, NGS has attracted attention over the past few years as a possible method for mutational analysis.
Although the sensitivity of NGS is superior to that of direct F I G U R E 2 Detection of low-frequency mutations of G17V RHOA using droplet digital PCR (ddPCR) assay and peptide nucleic acid-locked nucleic acid (PNA-LNA) clamp method with G17V probe. A, 2D images of ddPCR analysis of samples PTCL171, PTCL186, PTCL209, and PTCL259. Pink color lines indicate FAM (horizontal) and HEX (vertical) threshold. B, Amplification curves produced by PNA-LNA clamp method with G17V probe for samples PTCL171, PTCL186, PTCL209, and PTCL259. PTCL, peripheral T-cell lymphoma. NC, negative control; PC, positive control sequencing, our findings suggest that NGS cannot detect low allele mutations.
Recently, the ddPCR assay has been widely used to detect genetic and epigenetic alterations. [18] [19] [20] [21] ddPCR can detect very rare sequences with high precision and sensitivity by partitioning individual target molecules within distinct compartments and, therefore, reduces the limitations of conventional methods such as classic real-time quantitative PCR (qPCR) or the amplification refractory mutation system qPCR (ARMS qPCR). [22] [23] [24] However, the PNA-LNA clamp method is a molecular probe-based PCR method; its unique design and allele-specific approach allow exceptionally high specificity and sensitivity. 25, 26 The NGS platform is more convenient for massive parallel sequencing of known and unknown mutations in multiple genes. 27 In contrast, to detect a known target mutation within a single gene, both the value for interpretation of the result, whereas ddPCR is independent of the Cq value and requires a relatively small amount of initial DNA. 23, 24 However, the PNA-LNA clamp method is less expensive and clinically more accessible for mutation screening compared to ddPCR or NGS. 28 To date, quantitative allele-specific PCR and other methods are being tried to detect the G17V RHOA mutation. 17 Several hotspot mutations such as V617F JAK2 in myeloproliferative neoplasms, 29 V600E BRAF in hairy cell leukemia, 30 L265P MYD88 in Waldenstr€ om macroglobulinemia, 31 and D661Y/Y640F/S614R STAT3 in large granular lymphocytic leukemia 32 are being used for diagnostic purposes by means of NGS, 33 ddPCR, 34 ARMS-PCR, 35 allele-specific PCR, 36 high resolution melting, 37 qPCR, 38 and so on. The present study is the first report to evaluate the use of the ddPCR assay and the PNA-LNA clamp method for detection of low abundance RHOA G17V mutation.
In conclusion, our findings shed light on the potential of these techniques for the molecular diagnosis of AITL. 
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